Major Depressive Disorder Clinical Trials in Philadelphia, Pennsylvania
15 recruitingPhiladelphia, Pennsylvania
Showing 1–15 of 15 trials
Recruiting
Phase 2
Pramipexole Versus Escitalopram to Treat Major Depressive Disorder (MDD) and Comorbid MDD With Mild Neurocognitive Disorder (MND) in Persons With HIV
Mild Neurocognitive DisorderMajor Depressive DisorderHIV
National Institute of Allergy and Infectious Diseases (NIAID)186 enrolled41 locationsNCT06705478
Recruiting
Phase 3
A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
DepressionDepression - Major Depressive DisorderDepression in Adults+3 more
Cybin IRL Limited330 enrolled67 locationsNCT06793397
Recruiting
Phase 3
A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)
Major Depressive Disorder
Definium Therapeutics US, Inc.165 enrolled27 locationsNCT07592689
Recruiting
Phase 2
A Phase 2 Study of Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder
Major Depressive Disorder
Syndeio Biosciences, Inc164 enrolled32 locationsNCT07115329
Recruiting
Triage Survey for Psychiatry Research Eligibility
Major Depressive DisorderGeneralized Anxiety DisorderBorderline Personality Disorder
Adams Clinical20,000 enrolled6 locationsNCT05800925
Recruiting
Phase 3
Study to Assess the Safety and Effectiveness of NMRA-335140-501
Major Depressive Disorder
Neumora Therapeutics, Inc.1,000 enrolled178 locationsNCT06029439
Recruiting
Phase 3
Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
Major Depressive Disorder
Neurocrine Biosciences850 enrolled87 locationsNCT06966401
Recruiting
Early Phase 1
Pilot Study: Establishing Glutamatergic Changes in Rapid Antidepressant Effects of Ketamine
Major Depressive Disorder (MDD)
University of Pennsylvania10 enrolled1 locationNCT06788249
Recruiting
Phase 3
NBI-1065845-MDD3026: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
Major Depressive Disorder
Neurocrine Biosciences200 enrolled30 locationsNCT06963021
Recruiting
Phase 3
Study to Assess the Effects of Oral NMRA-335140 Versus Placebo in Participants With Major Depressive Disorder
Major Depressive Disorder
Neumora Therapeutics, Inc.332 enrolled74 locationsNCT06058013
Recruiting
Not Applicable
Taking Action for College Students
SchizophreniaMajor Depressive DisorderBipolar Disorder
Temple University300 enrolled1 locationNCT06700902
Recruiting
Not Applicable
Neurofeedback to Treat Depression - 2
Major Depressive Disorder (MDD)
University of Pennsylvania80 enrolled1 locationNCT07159061
Recruiting
Not Applicable
Decoding and Modulating Affective Brain States
AnxietyMajor Depressive DisorderRumination
University of Pennsylvania40 enrolled1 locationNCT05437705
Recruiting
Phase 3
Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder
Major Depressive Disorder
Intra-Cellular Therapies, Inc.470 enrolled60 locationsNCT05850689
Recruiting
Not Applicable
Getting Out of the House: Using Behavioral Activation to Increase Community Participation
SchizophreniaMajor Depressive DisorderBipolar Disorder+1 more
Temple University52 enrolled1 locationNCT06336616